Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder

Journal of Clinical Psychiatry

Volumn 74, Issue 5, 2013, Pages 464-469

  Foa, Edna B ^a   Simpson, Helen Blair ^b,c   Liebowitz, Michael R ^b,c   Powers, Mark B ^d   Rosenfield, David ^d   Cahill, Shawn P ^e   Campeas, Raphael ^b,c   Franklin, Martin ^a   Hahn, Chang Gyu ^a   Hembree, Elizabeth A ^a   Huppert, Jonathan D ^a,f   Schmidt, Andrew B ^h   Vermes, Donna ^b   Williams, Monnica T ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Department of Psychiatry Columbia University ^*  (United States)

^d Naveen Jindal School of Management   (United States)

^e UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^g UNIVERSITY OF LOUISVILLE   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; EXPOSURE AND RITUAL PREVENTION THERAPY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STRESS MANAGEMENT; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84878261458     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m08017     Document Type: Article

References (22)

1. Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005;162(1):151-161. doi:10.176/api.ajp.162.1.151 PubMed (Pubitemid 40095685)
2. Simpson HB, Foa EB, Liebowitz MR, et al. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry. 2008;165(5):621-630. doi:10.176/api.ajp.207.0709140 PubMed (Pubitemid 351705340)
3. Tenneij NH, van Megen HJ, Denys DA, et al. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry. 2005;66(9):1169-1175. doi:10.408/JCP.v6n0913 PubMed (Pubitemid 41442285)
4. Foa EB, Kozak MJ. Psychological treatment for obsessive-compulsive disorder. In: Mavissakalian MR, Prien RF, eds. Long-Term Treatments of Anxiety Disorders. Washington, DC: American Psychiatric Press; 1996: 285-309.
5. Simpson HB, Liebowitz MR, Foa EB, et al. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depress Anxiety. 2004;19(4):225-233. doi:10.102/da.203 PubMed (Pubitemid 39014142)
6. van Oppen P, van Balkom AJ, de Haan E, et al. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. J Clin Psychiatry. 2005; 66( 11): 1415-1422. doi:10.408/JCP.v6n1 PubMed
7. Whittal ML, Robichaud M, Thordarson DS, et al. Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: a 2-year follow-up of two randomized trials. J Consult Clin Psychol. 2008; 76( 6): 1003-1014. doi:10.1037/a013076 PubMed
8. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
9. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. doi:10.101/archpsyc.1989.01810104807 PubMed (Pubitemid 19278229)
10. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 2: validity. Arch Gen Psychiatry. 1989;46(11):1012-1016. doi:10.101/archpsyc.1989.01810105408 PubMed (Pubitemid 19278230)
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23( 1): 56-62. doi:10.136/jnp.23.1.56 PubMed
12. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32( 1): 50-55. doi:10.1/j.204-8341.1959.tb0467.x PubMed
13. Foa EB, Huppert JD, Leiberg S, et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002;14(4):485-496. doi:10.1037/1040-3590.14.4.485 PubMed (Pubitemid 35440493)
14. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-326. PubMed (Pubitemid 23311543)
15. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 1976; 33( 9): 1111-1115. doi:10.101/archpsyc. 1976.017090101010 PubMed
16. Simpson HB, Huppert JD, Petkova E, et al. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(2):269-276. doi:10.408/JCP.v67n0214 PubMed (Pubitemid 43357474)
17. Hedeker D, Gibbons RD. Longitudinal Data Analysis. Hoboken, NJ: John Wiley & Sons; 2006.
18. Singer JD, Willett JB. Applied Longitudinal Data Analysis . New York, NY: Oxford University Press; 2003. doi:10.1093/acprof:oso/9780195152968.01.01
19. Maher MJ, Huppert JD, Chen H, et al. Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder. Psychol Med. 2010; 40( 12): 2013-2023. doi:10.1017/S03291710620 PubMed
20. Whittal ML, Thordarson DS, McLean PD. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs exposure and response prevention. Behav Res Ther. 2005;43(12):1559-1576. doi:10.1016/j.brat.204.1.012 PubMed (Pubitemid 41464360)
21. Foa, E. B., Grayson, J. B., Steketee, G. S., et al. Success and failure in the behavioral treatment of obsessive-compulsives. J Consult ClinPsychol, 1983;51(2):287-297. PubMed (Pubitemid 14247267)
22. Anholt GE, Aderka IM, van Balkom AJ, et al. The impact of depression on the treatment of obsessive-compulsive disorder: results from a 5-year follow-up. J Affect Disord. 2011; 135( 1- 3): 201-207. PubMed